Effect of RNA interference targeting human telomerase reverse transcriptase on telomerase and its related protein

Yan Wang1, Hong-Gang Duan, Shi-Ming Chen

  • 1Department of Otolaryngology-Head and Neck Surgery, Renmin Hospital of Wuhan University, Wuhan, People's Republic of China.

Abstract

Insights

Short hairpin RNA targeting human telomerase reverse transcriptase messenger RNA inhibited nasopharyngeal carcinoma cell viability. This RNA interference approach regulated telomerase activity and related protein expression, suggesting a potential cancer treatment strategy.

Area of Science:

  • Oncology
  • Molecular Biology
  • Genetics

Background:

  • Nasopharyngeal carcinoma (NPC) is a significant health concern.
  • Understanding the molecular mechanisms of NPC carcinogenesis is crucial for developing effective treatments.
  • Telomerase plays a role in cancer development and progression.

Purpose of the Study:

  • To investigate the effect of short hairpin RNA (shRNA) targeting human telomerase reverse transcriptase (hTERT) messenger RNA (mRNA) on nasopharyngeal carcinoma cells.
  • To analyze the correlation between telomerase activity and the expression of c-myc, proliferating cell nuclear antigen (PCNA), and Caspase-3.
  • To explore the potential of RNA interference (RNAi) as a therapeutic strategy for NPC.

Main Methods:

  • Construction of shRNA expression vectors targeting hTERT mRNA.
  • Treatment of NPC cells with hTERT-specific shRNA or control vectors.
  • Measurement of telomerase activity using telomeric repeat amplification enzyme-linked immunosorbent assay (TRAP-ELISA).
  • Assessment of cell viability via MTT assay.
  • Determination of protein expression levels (c-myc, PCNA, Caspase-3) using Western blotting.

Main Results:

  • hTERT-specific shRNA significantly inhibited telomerase activity in NPC cells.
  • Expression of c-myc and PCNA was downregulated.
  • Expression of Caspase-3 was upregulated, indicating increased apoptosis.
  • Cell viability was significantly reduced.

Conclusions:

  • shRNA targeting hTERT effectively inhibits NPC cell viability by modulating telomerase activity and related protein expression.
  • RNA interference targeting hTERT presents a promising therapeutic strategy for nasopharyngeal cancer.
  • Further research into RNAi-based therapies for NPC is warranted.

Related Concept Videos

Telomeres and Telomerase02:41

Telomeres and Telomerase

In eukaryotic DNA replication, a single-stranded DNA fragment remains at the end of a chromosome after the removal of the final primer. This section of DNA cannot be replicated in the same manner as the rest of the strand because there is no 3’ end to which the newly synthesized DNA can attach. This non-replicated fragment results in gradual loss of the chromosomal DNA during each cell duplication. Additionally, it can induce a DNA damage response by enzymes that recognize single-stranded DNA.
Experimental RNAi02:15

Experimental RNAi

RNA interference (RNAi) is a cellular mechanism that inhibits gene expression by suppressing its transcription or activating the RNA degradation process. The mechanism was discovered by Andrew Fire and Craig Mello in 1998 in plants. Today, it is observed in almost all eukaryotes, including protozoa, flies, nematodes, insects, parasites, and mammals. This precise cellular mechanism of gene silencing has been developed into a technique that provides an efficient way to identify and determine the...
RNA Interference01:23

RNA Interference

RNA interference (RNAi) is a process in which a small non-coding RNA molecule blocks the post-transcriptional expression of a gene by binding to its messenger RNA (mRNA) and preventing the protein from being translated.
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
RNA Interference01:23

RNA Interference

RNA interference (RNAi) is a process in which a small non-coding RNA molecule blocks the post-transcriptional expression of a gene by binding to its messenger RNA (mRNA) and preventing the protein from being translated.
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
Replicative Cell Senescence02:15

Replicative Cell Senescence

Replicative cell senescence is a property of cells that allows them to divide a finite number of times throughout the organism's lifespan while preventing excessive proliferation. Replicative senescence is associated with the gradual loss of the telomere — short, repetitive DNA sequences found at the end of the chromosomes. Telomeres are bound by a group of proteins to form a protective cap on the ends of chromosomes. Embryonic stem cells express telomerase — an enzyme that adds the telomeric...
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA ends...